384 related articles for article (PubMed ID: 12836160)
1. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.
Samland H; Huitron-Resendiz S; Masliah E; Criado J; Henriksen SJ; Campbell IL
J Neurosci Res; 2003 Jul; 73(2):176-87. PubMed ID: 12836160
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6.
Giralt M; Penkowa M; Hernández J; Molinero A; Carrasco J; Lago N; Camats J; Campbell IL; Hidalgo J
Neurobiol Dis; 2002 Apr; 9(3):319-38. PubMed ID: 11950277
[TBL] [Abstract][Full Text] [Related]
5. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6.
Carrasco J; Hernandez J; Gonzalez B; Campbell IL; Hidalgo J
Exp Neurol; 1998 Oct; 153(2):184-94. PubMed ID: 9784278
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Otani N; Nawashiro H; Fukui S; Ooigawa H; Ohsumi A; Toyooka T; Shima K; Gomi H; Brenner M
J Clin Neurosci; 2006 Nov; 13(9):934-8. PubMed ID: 17085299
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat.
Hidalgo J; Florit S; Giralt M; Ferrer B; Keller C; Pilegaard H
Brain Behav Immun; 2010 Jan; 24(1):119-26. PubMed ID: 19748567
[TBL] [Abstract][Full Text] [Related]
9. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
10. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
12. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions.
Pasinetti GM; Tocco G; Sakhi S; Musleh WD; DeSimoni MG; Mascarucci P; Schreiber S; Baudry M; Finch CE
Neurobiol Dis; 1996; 3(3):197-204. PubMed ID: 8980020
[TBL] [Abstract][Full Text] [Related]
13. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
14. Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10.
Woiciechowsky C; Schöning B; Stoltenburg-Didinger G; Stockhammer F; Volk HD
Med Sci Monit; 2004 Sep; 10(9):BR325-30. PubMed ID: 15328477
[TBL] [Abstract][Full Text] [Related]
15. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
16. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
17. Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain.
Sanz E; Hofer MJ; Unzeta M; Campbell IL
Glia; 2008 Jan; 56(2):190-9. PubMed ID: 18023015
[TBL] [Abstract][Full Text] [Related]
18. [Astrocyte activation and Bcl-2 protein expression induced by lipopolysaccharide in mouse brain].
Deng XH; Liu S; Cai WJ; Lei DL; Luo XG
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):401-7. PubMed ID: 17611314
[TBL] [Abstract][Full Text] [Related]
19. Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome.
Quintana A; Molinero A; Borup R; Nielsen FC; Campbell IL; Penkowa M; Hidalgo J
Dev Neurobiol; 2008 Feb; 68(2):195-208. PubMed ID: 18000830
[TBL] [Abstract][Full Text] [Related]
20. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes.
Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L
Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
